George M. Scarmon, Md | |
1530 3rd St Suite 106 Lincoln CA 95648-1562 | |
(916) 645-3388 | |
(916) 645-6159 |
Full Name | George M. Scarmon, Md |
---|---|
Speciality | Family Medicine |
Location | 1530 3rd St, Lincoln, California |
Authorized Official Name and Position | George M Scarmon (OWNER/PROVIDER) |
Authorized Official Contact | 9166453388 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
George M. Scarmon, Md 1530 3rd St Suite 106 Lincoln CA 95648-1562 Ph: (916) 645-3388 | George M. Scarmon, Md 1530 3rd St Suite 106 Lincoln CA 95648-1562 Ph: (916) 645-3388 |
NPI Number | 1073709465 |
---|---|
Provider Enumeration Date | 09/19/2007 |
Last Update Date | 08/29/2008 |
Identifier | Type | State | Issuer |
---|---|---|---|
1073709465 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 00G255140 (California) | Primary |
News Archive
Researchers at the Universitat de València, Universitat Politècnica de València (UPV), Doctor Peset University Hospital and the Institute of Agrochemistry and Food Technology of CSIC have designed and tested the effectiveness of a new apple snack impregnated with tangerine juice that reduces the risk of cardiovascular disease in obese children and improves their physiological well-being.
Today the U.S. Food and Drug Administration (FDA) released two separate draft guidance documents to help fight the tobacco epidemic and stop children from using tobacco. The draft guidance documents implement provisions of the Family Smoking Prevention and Tobacco Control Act that will ultimately provide the public with previously unknown information about the chemicals in tobacco products and help prevent misleading marketing about the risks associated with tobacco products.
Researchers from the various Massachusetts hospitals performed the Boston Area COVID-19 Consortium (BACC) Bay Tocilizumab Trial using tocilizumab administered early in the disease course to determine if early IL-6 receptor blockade limits progression of COVID-19 to hypoxemic respiratory failure or death. Their work is published in the prestigious New England Journal of Medicine.
Omeros Corporation today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of thrombotic microangiopathies (TMAs). TMAs are a family of rare, debilitating and life-threatening disorders characterized by excessive thrombi (clots) – aggregations of platelets – in the microcirculation of the body's organs, most commonly the kidney and brain.
› Verified 6 days ago
Lincoln Medical Associates, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1530 3rd St, Suite 106, Lincoln, CA 95648 Phone: 916-645-3388 | |
Northern Sierra Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 745 S State Highway 65, Ste 20 Pmb 216, Lincoln, CA 95648 Phone: 916-295-4159 | |
Lincoln Internal Medicine, A Medical Corp. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 801 Sterling Parkway #120, Suite D, Lincoln, CA 95648 Phone: 916-408-3773 Fax: 916-408-3853 | |
Linconln Family Practice Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 151 E 12th St, Lincoln, CA 95648 Phone: 916-434-1623 Fax: 916-434-1625 | |
Lincoln Medical Practice Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 89 Lincoln Blvd, Lincoln, CA 95648 Phone: 916-434-8800 | |
Teng Medical Foundation Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 831 Sterling Pkwy Ste 110, Lincoln, CA 95648 Phone: 916-253-9898 |